Option chain shows key data for Gruma SAB's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Gruma SAB.

Gruma SAB (OTC:GMKKY) Stock, Option Chain

Gruma SAB de CV is an international food production company, originally from Mexico. The product portfolio is large: corn and flour tortillas, wheat flour, naan, pita bread, flatbreads, wraps, chapatti, and pizza bases, along with other food products, such as snacks, pasta, rice, condiments, and palm hearts. The company has operations in America, Europe, Asia, and Oceania, and is present in over 100 countries across the globe. Its well-known brands are Maseca, Robin Hood, Mission, Guerrero, Tortiricas and Tosty.

GRUMA SAB DE CV UNSP/ADR by Gruma S.A.B. de CV

Gruma SAB de CV

Organogenesis Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGO#NASDAQ">ORGO</a>), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way in Smithfield, Rhode Island.

News

ORGO

Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island

BBIO

Trading Halt: Halted at 4:08:53 p.m. ET - Trading Halt: Halt News Pending

Contracts

JZXN

Jiuzi Holdings And Shenzhen Maigesong Announced They Have Terminated Acquisition Negotiations To Focus On Future Growth

Initial meeting adjourned due to insufficient votes to reach the 50% threshold of outstanding common shares voting in favor of Proposal One and Proposal Two
Stockholders who have not voted are strongly encouraged to vote FOR Proposal One and Proposal Two
NovaBay&#xAE; Pharmaceuticals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBY#NYSE">NBY</a>) ("NovaBay" or the "Company") announces that its Special Meeting of Stockholders held on November 22, 2024 has been adjourned until December 18, 2024 at 11:00 a.m. Pacific time to provide stockholders additional time to vote on Proposal One and Proposal Two. Both proposals received significant support based on the shares that have been voted by stockholders but have yet to reach the 50% threshold of favorable votes of all outstanding shares of common stock required to approve each proposal.
<ul>
<li>Proposal One is a proposal to approve the sale of Avenova, representing substantially all of the assets of the Company (the "Asset Sale"), pursuant to the Asset Purchase Agreement, dated September 19, 2024, by and between the Company and PRN Physician Recommended Nutriceuticals, LLC.
<ul>
<li>Proposal Two is a proposal to approve the liquidation and dissolution of the Company, pursuant to the Plan of Complete Liquidation and Dissolution of the Company (the "Plan of Dissolution") which, if approved, would authorize the Company to liquidate and dissolve in accordance with the Plan of Dissolution, and pursuant to the discretion of the Board of Directors to proceed with the dissolution.</li>
</ul>
</li>
</ul>

NovaBay Pharmaceuticals To Reconvene Special Meeting Of Stockholders To December 18, 2024; Initial Meeting Adjourned Due To Insufficient Votes To Reach The 50% Threshold Of Outstanding Common Shares Voting In Favor Of Proposal One And Two

<h3>Gainers</h3>
<ul>
<li>Alta Global Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MMA#AMEX">MMA</a>) shares moved upwards by 25.1% to $2.27 during Friday's pre-market session. The company's market cap stands at $23.7 million. </li>
<li>Gap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) stock increased by 17.8% to $25.96. The company's market cap stands at $9.7 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) stock moved upwards by 12.38% to $0.8. The market value of their outstanding shares is at $36.6 million. </li>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) stock increased by 11.46% to $0.57. The market value of their outstanding shares is at $36.7 million. </li>
<li>Sunlands Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STG#NYSE">STG</a>) shares moved upwards by 8.18% to $7.14. The company's market cap stands at $97.9 million. The company's, Q3 earnings came out today. </li>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) stock moved upwards by 8.1% to $1.6. The company's market cap stands at $6.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cato (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CATO#NYSE">CATO</a>) shares fell 11.3% to $4.4 during Friday's pre-market session. The company's market cap stands at $90.5 million. The company's, Q3 earnings came out yesterday. </li>
<li>Destination XL Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) stock decreased by 6.21% to $2.42. The market value of their outstanding shares is at $140.9 million. As per the press release, Q3 earnings came out today. </li>
<li>Vision Marine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>) stock declined by 6.11% to $2.6. The company's market cap stands at $2.3 million. </li>
<li>Interactive Strength (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares fell 5.75% to $3.77. The company's market cap stands at $2.3 million. </li>
<li>SAG Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAG#NASDAQ">SAG</a>) stock declined by 5.21% to $2.55. The market value of their outstanding shares is at $25.1 million. </li>
<li>Thunder Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIEV#NASDAQ">AIEV</a>) stock declined by 4.99% to $0.27. The company's market cap stands at $13.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AIEV

ALUR

CATO

DXLG

GDHG

NDLS

TRNR

VMAR

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) stock rose 41.7% to $15.39 during Friday's pre-market session. The company's market cap stands at $33.4 million. </li>
<li>Virpax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) stock rose 34.76% to $0.79. The market value of their outstanding shares is at $6.4 million. </li>
<li>Replimune Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) stock moved upwards by 23.07% to $13.6. The company's market cap stands at $930.4 million. </li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) shares increased by 20.27% to $1.78. The company's market cap stands at $2.2 million. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) stock rose 12.58% to $3.4. The market value of their outstanding shares is at $2.9 million. As per the press release, Q3 earnings came out today. </li>
<li>IO Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>) stock rose 12.56% to $0.77. The company's market cap stands at $50.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) stock decreased by 55.0% to $6.08 during Friday's pre-market session. The company's market cap stands at $7.0 million. </li>
<li>Evotec (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) stock fell 17.01% to $4.44. The company's market cap stands at $1.5 billion. </li>
<li>Procaps Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROC#NASDAQ">PROC</a>) shares decreased by 14.42% to $0.95. The market value of their outstanding shares is at $107.1 million. </li>
<li>BioXcel Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTAI#NASDAQ">BTAI</a>) shares decreased by 8.87% to $0.52. The company's market cap stands at $22.2 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares fell 7.93% to $0.29. The company's market cap stands at $4.2 million. </li>
<li>TruBridge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBRG#NASDAQ">TBRG</a>) shares declined by 7.88% to $14.75. The market value of their outstanding shares is at $220.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMIX

BTAI

IOBT

LIFW

PROC

REPL

SCNI

SLXN

TBRG

VRPX

XCUR

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>SKK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKK#NASDAQ">SKK</a>) shares increased by 75.4% to $1.93 during Friday's pre-market session. The market value of their outstanding shares is at $30.1 million. </li>
<li>Jet AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) stock moved upwards by 39.24% to $8.48. The company's market cap stands at $6.6 million. </li>
<li>Icon Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICON#NASDAQ">ICON</a>) stock increased by 23.5% to $2.68. The market value of their outstanding shares is at $4.3 million. </li>
<li>Aqua Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQMS#NASDAQ">AQMS</a>) stock moved upwards by 12.15% to $2.03. The market value of their outstanding shares is at $14.4 million. </li>
<li>Matthews International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATW#NASDAQ">MATW</a>) shares moved upwards by 11.8% to $28.5. The company's market cap stands at $875.2 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Marti Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MRT#AMEX">MRT</a>) stock increased by 11.32% to $2.16. The market value of their outstanding shares is at $123.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Knightscope (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSCP#NASDAQ">KSCP</a>) shares fell 31.1% to $12.61 during Friday's pre-market session. The market value of their outstanding shares is at $48.1 million. </li>
<li>Flux Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>) shares declined by 11.82% to $2.09. The company's market cap stands at $34.8 million. </li>
<li>Caravelle Intl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCO#NASDAQ">HTCO</a>) stock fell 9.1% to $1.1. The company's market cap stands at $61.3 million. </li>
<li>L.B. Foster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTR#NASDAQ">FSTR</a>) shares decreased by 8.33% to $25.0. The company's market cap stands at $270.7 million. </li>
<li>ESGL Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESGL#NASDAQ">ESGL</a>) stock fell 6.78% to $1.63. The market value of their outstanding shares is at $65.5 million. </li>
<li>Satellogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATL#NASDAQ">SATL</a>) stock decreased by 5.52% to $1.2. The company's market cap stands at $108.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AQMS

ESGL

FLUX

FSTR

HTCO

ICON

JTAI

KSCP

MATW

SATL

12 Industrials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Wellchange Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WCT#NASDAQ">WCT</a>) shares increased by 76.8% to $2.21 during Friday's pre-market session. The market value of their outstanding shares is at $46.9 million. </li>
<li>Arqit Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQQ#NASDAQ">ARQQ</a>) shares increased by 17.15% to $12.5. The company's market cap stands at $85.3 million. </li>
<li>Thumzup Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>) stock increased by 16.04% to $4.7. The market value of their outstanding shares is at $44.1 million. </li>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) stock rose 14.37% to $4.6. The market value of their outstanding shares is at $22.2 million. </li>
<li>Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) shares rose 14.18% to $1.69. The market value of their outstanding shares is at $324.9 million. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) shares rose 13.76% to $0.25. The company's market cap stands at $4.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Logility Supply Chain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGTY#NASDAQ">LGTY</a>) shares fell 18.8% to $9.09 during Friday's pre-market session. The company's market cap stands at $322.5 million. The company's, Q2 earnings came out yesterday. </li>
<li>Digital Ally (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGLY#NASDAQ">DGLY</a>) stock decreased by 13.05% to $0.84. The market value of their outstanding shares is at $3.9 million. </li>
<li>Akoustis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTS#NASDAQ">AKTS</a>) stock fell 8.05% to $0.1. The market value of their outstanding shares is at $14.8 million. </li>
<li>Veea (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEA#NASDAQ">VEEA</a>) shares declined by 7.64% to $2.3. The market value of their outstanding shares is at $81.9 million. The company's, Q3 earnings came out 2 days ago. </li>
<li>Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) stock declined by 7.18% to $7.63. The company's market cap stands at $45.6 million. </li>
<li>Global Engine Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLE#NASDAQ">GLE</a>) stock declined by 6.87% to $4.07. The market value of their outstanding shares is at $74.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKTS

ARQQ

DGLY

LGTY

QMCO

RGTI

TZUP

VEEA

12 Information Technology Stocks Moving In Friday's Pre-Market Session

EVLV

Evolv Receives Nasdaq Delinquency Notification

Offerings

IMNM

Immunome Files For Resale Of Up To 1.8M Shares By Selling Stockholder

Petrobras Brasileiro Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBR#NYSE">PBR</a>) shares are trading higher Friday, following approval of $3.4 billion in extraordinary dividends by its board. Here&#8217;s <a href="https://www.benzinga.com/quote/PBR/news">what you need to know.</a>
What To Know: Petrobras stated that approximately 15.6 billion reals (approximately $2,685,997,080) of the payout would come from a capital reserve. The reserve had been holding cash investors expected to receive earlier as extraordinary dividends for the 2023 period.
Earlier in the week, Petrobras <a href="https://www.benzinga.com/24/11/42137060/petrobras-boosts-five-year-investment-to-111b-aims-for-32m-boed-production">announced its strategic plan</a> for 2025-2029, outlining $111 billion in investments, including $77 billion for exploration and production and $20 billion for refining, transportation and sales. The plan also emphasizes a focus on sustainable practices, such as reducing the carbon footprint of its operations and prioritizing pre-salt asset development.
The company expects total production of 3.2 million barrels of oil and gas equivalent per day during the period and plans to distribute $45 billion to $55 billion in ordinary dividends, with an additional $10 billion reserved for extraordinary dividends or projects.
PBR Price Action: Petrobas Brasileiro shares were up 5.19% at $14.89 at the time of publication on Friday, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="552" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22152312/PBR-1024x552.png" alt="" class="wp-image-661697" style="width:544px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22152312/PBR-1024x552.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22152312/PBR-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22152312/PBR-768x414.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22152312/PBR.png 1129w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42146459/bitcoin-on-brink-of-breaking-100000-dogecoin-up-ethereum-down-crypto-community-holds-its-breath-as-btc-guns-for-milestone">Bitcoin &#8216;On Brink Of Breaking $100,000,&#8217; Dogecoin Up, Ethereum Down: Crypto Community Holds Its Breath As BTC Guns For Milestone</a></li>
</ul>
Photo: Shutterstock.

Dividends

Commodities

Global

Petrobras Shares Are On The Rise Today: What's Going On?

CREV

Carbon Revolution Receives Nasdaq Non-Compliance Notice for Delayed Annual Report Filing; Has Until January 21, 2025, to Submit Compliance Plan

Orange County Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBT#NASDAQ">OBT</a>), parent company of Orange Bank &amp; Trust Company and Hudson Valley Investment Advisors, Inc. today announced a $0.02 increase and a declaration of a $0.25 cash dividend per share of its common stock. The dividend will be paid on December 16, 2024 to shareholders of record on December 4, 2024.

Orange County Bancorp Increases Quarterly Cash Dividend From $0.23 To $0.25 Per Share

Despite flat earnings and challenging market conditions, Cresco Labs Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) remains an &#8220;Overweight&#8221; stock, according to analysis firm Zuanic &amp; Associates. In his latest report, Zuanic underscores Cresco&#8217;s strong positioning in emerging adult-use markets such as Pennsylvania and Ohio while identifying valuation advantages that set the company apart. 
Cresco trades at 5.5x forward EBITDA, below Green Thumb Industries Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) at 7x and Curaleaf Holdings Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) at 10x. 
&#8220;This discount presents an appealing entry point for investors looking beyond short-term volatility,&#8221; Zuanic writes.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. You can't afford to miss out if you&#8217;re serious about the business.</li>
</ul>
<h3 class="wp-block-heading">Market Dynamics: Cresco In The Tier 1 Landscape</h3>
Zuanic's report benchmarks Cresco against other Tier 1 multi-state operators (MSOs), including Green Thumb, Trulieve Cannabis Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>), Verano Holdings Corp. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VRNOF#OTC">VRNOF</a>), and Curaleaf.&nbsp;
While Cresco&#8217;s third-quarter revenue of $180 million fell 2% sequentially, the decline aligns with broader industry trends, with peers like Curaleaf and Verano posting declines of 3% and 5%, respectively. By contrast, Green Thumb achieved a 2% increase, reaching $287 million.
<a href="https://www.benzinga.com/cannabis/earnings">Adjusted EBITDA margins </a>further illustrate Cresco's position: the company held steady at 29% in Q3, compared to Green Thumb at 31% (-200 basis points) and Trulieve at 34% (-100 basis points). However, <a href="https://www.benzinga.com/quote/CRLBF">Cresco lags in adjusted cash flow.</a>&nbsp;
Its negative $3 million adjusted figure for the first nine months of 2024, factoring in tax liabilities, contrasts sharply with Green Thumb's $139 million (17% of sales) and Trulieve's $37 million (4% of sales). <a href="https://www.benzinga.com/topic/pablo-zuanic">Zuanic highlights</a> cash flow conversion as a critical area where Cresco &#8216;lags&#8217; its competitors.&#8221;&nbsp;
Read Also: <a href="https://www.benzinga.com/24/11/42145406/nebraskas-cannabis-legalization-faces-courtroom-showdown-over-alleged-fraud">Nebraska&#8217;s Cannabis Legalization Faces Courtroom Showdown Over Alleged Fraud</a>
<h3 class="wp-block-heading">Valuation Analysis: Digging Into The Numbers</h3>
Cresco's <a href="https://www.benzinga.com/cannabis/earnings">valuation metrics reveal potential upside</a>. Its enterprise value (EV) to current sales ratio stands at 1.6x, lower than Curaleaf and Green Thumb, both at 2.2x. This discount extends to EV-to-EBITDA multiples, with Cresco trading at 5.5x compared to Green Thumb at 7x and Curaleaf at 10x.&nbsp;
These figures include tax liabilities, financial net debt, and other obligations. "Cresco's lower EV multiples, alongside its gross cash holdings of $157 million, make it a compelling value play among Tier 1 operators," Zuanic explains.
<h3 class="wp-block-heading">Strategic Hurdles And Growth Catalysts</h3>
Despite these advantages, Zuanic identifies several hurdles. Cresco&#8217;s total leverage, including financial and tax liabilities, amounts to 80% of trailing sales, the highest among Tier 1 MSOs. In contrast, Green Thumb's leverage is just 9%. Moreover, while Cresco holds promising positions in <a href="https://www.benzinga.com/topic/pennsylvania-cannabis">Pennsylvania</a> and <a href="https://www.benzinga.com/topic/ohio-cannabis">Ohio</a>, Zuanic emphasizes the need for a strategic partner to close the scale gap with peers like Green Thumb and Curaleaf. &#8220;A partnership would help Cresco achieve operational efficiencies and capitalize on upcoming recreational markets,&#8221; he notes.
Zuanic&#8217;s projections account for regulatory uncertainty, including delays in Pennsylvania's adult-use legalization timeline to mid-2026 and the potential impact of federal rescheduling challenges. Nonetheless, he remains optimistic about Cresco's long-term prospects. &#8220;We see Cresco as a buy for investors with a one-to-two-year horizon, particularly given its discounted valuation,&#8221; he concludes. 
For a deeper dive into his methodology and projections, <a href="https://zuanicgroup.com/">visit Zuanic &amp; Associates' research portal</a>.
Read Next: <a href="https://www.benzinga.com/24/11/42144540/dea-slammed-over-unlawful-talks-with-cannabis-opponents-the-plot-thickens">DEA Slammed For Unlawful Talks With Cannabis Opponents &#8211; The Plot Thickens</a>

Analyst Color

Cannabis

Market Summary

Retail Sales

Small Cap

Exclusives

Markets

Analyst Ratings

Trading Ideas

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GTBIF

TCNNF

VRNOF

80% Leverage, 5.5x EBITDA: Is Cresco The High-Risk, High-Reward Play Investors Need?

WIIM

General Motors shares are trading higher amid rumors the company may potentially enter F1 in 2026.

Ford Motor Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) shares are trading higher Friday. There were multiple developments this week, including unionization efforts at its Kentucky battery plant and broader industry calls to President-elect Donald Trump to preserve key EV tax credits. Here&#8217;s <a href="https://www.benzinga.com/quote/F/news">what you need to know.</a>
What To Know: Earlier this week, the United Auto Workers (UAW) announced that a supermajority of workers at Ford's BlueOval SK battery plant in Kentucky, a joint venture with SK On, <a href="https://www.benzinga.com/24/11/42104199/supermajority-of-workers-at-fords-jv-battery-plant-sign-union-authorization-cards-says-uaw">signed union authorization cards</a>.
The workers cited pay and benefit disparities compared to unionized Ford employees as key motivators. UAW stated that BlueOval SK workers earn significantly less than their unionized counterparts, starting pay at $21 per hour compared to $26.32 for Ford's UAW production workers.
Additionally, a group representing major automakers, including Ford, urged the incoming Trump administration to preserve the $7,500 federal tax credit for electric vehicle purchases and support self-driving car technologies. The group also expressed concerns over emissions regulations and potential revisions to rules mandating automatic emergency braking systems. This lobbying effort potentially highlights the auto industry&#8217;s focus on sustaining momentum in EV and autonomous vehicle development while addressing regulatory challenges.
What Else: On Wednesday, the company announced plans to cut about 4,000 jobs or 14% of its European workforce, due to weak demand for electric vehicles and increasing competition. The layoffs, representing 2.3% of Ford&#8217;s global headcount, are expected to occur by the end of 2027. Ford&#8217;s European sales have dropped 17.9% this year, largely due to reduced EV subsidies in markets like Germany, contributing to the company&#8217;s challenges as its transition to electric vehicles.
F Price Action: Ford Motor shares were up 3.56% at $11.18 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent112224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="529" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22134601/F-1024x529.png" alt="" class="wp-image-661562" style="width:495px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22134601/F-1024x529.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22134601/F-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22134601/F-768x397.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22134601/F.png 1174w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Image via Shutterstock.

Ford Shares Are On The Rise Friday: What You Need To Know

Nike shares are trading higher after Needham initiated coverage on the stock with a Buy rating and announced a price target of $84.

ABBV

AbbVie shares are trading higher after Leerink Partners upgraded the stock from Market Perform to Outperform and announced a price target of $206.

Investors with a lot of money to spend have taken a bullish stance on Deere (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DE, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 16 uncommon options trades for Deere.
This isn't normal.
The overall sentiment of these big-money traders is split between 43% bullish and 43%, bearish.
Out of all of the special options we uncovered, 6 are puts, for a total amount of $301,147, and 10 are calls, for a total amount of $1,023,353.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $185.0 to $470.0 for Deere over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Deere's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Deere's whale trades within a strike price range from $185.0 to $470.0 in the last 30 days. 
<h3>Deere 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732308895_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$265.4</td>
<td>$261.2</td>
<td>$261.2</td>
<td>$185.00</td>
<td>$444.0K</td>
<td align="right">1</td>
<td align="right">17</td>
</tr>
<tr>
<td>DE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/22/24</td>
<td>$41.15</td>
<td>$33.7</td>
<td>$33.75</td>
<td>$397.50</td>
<td>$168.7K</td>
<td align="right">88</td>
<td align="right">50</td>
</tr>
<tr>
<td>DE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$23.0</td>
<td>$22.5</td>
<td>$23.0</td>
<td>$470.00</td>
<td>$138.0K</td>
<td align="right">239</td>
<td align="right">60</td>
</tr>
<tr>
<td>DE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$43.85</td>
<td>$42.85</td>
<td>$43.28</td>
<td>$400.00</td>
<td>$60.5K</td>
<td align="right">904</td>
<td align="right">20</td>
</tr>
<tr>
<td>DE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$7.05</td>
<td>$5.5</td>
<td>$6.1</td>
<td>$430.00</td>
<td>$51.8K</td>
<td align="right">104</td>
<td align="right">89</td>
</tr>
</tbody>
</table>

<h3>About Deere</h3>
Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry in their green and yellow livery. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 2,000 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.
In light of the recent options history for Deere, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Deere Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,458,238, the price of DE is up by 1.71%, reaching $445.02.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 83 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Deere</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $485.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Neutral rating on Deere with a target price of $450. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Deere, which currently sits at a price target of $538. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Deere, targeting a price of $475. 
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Deere with a target price of $477. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Deere options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Behind the Scenes of Deere's Latest Options Trends

Whales with a lot of money to spend have taken a noticeably bearish stance on Novo Nordisk.
Looking at options history for Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) we detected 25 trades.
If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 48% with bearish.
From the overall spotted trades, 11 are puts, for a total amount of $1,872,600 and 14, calls, for a total amount of $3,590,645.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $65.0 to $145.0 for Novo Nordisk during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Novo Nordisk's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Novo Nordisk's substantial trades, within a strike price spectrum from $65.0 to $145.0 over the preceding 30 days.
<h3>Novo Nordisk Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732308891_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$7.8</td>
<td>$7.6</td>
<td>$7.8</td>
<td>$102.00</td>
<td>$1.3M</td>
<td>270</td>
<td>1.7K</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.2</td>
<td>$4.9</td>
<td>$5.2</td>
<td>$100.00</td>
<td>$780.0K</td>
<td>4.6K</td>
<td>2.0K</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.85</td>
<td>$3.65</td>
<td>$3.84</td>
<td>$115.00</td>
<td>$686.9K</td>
<td>2.9K</td>
<td>1.9K</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$13.45</td>
<td>$13.1</td>
<td>$13.15</td>
<td>$105.00</td>
<td>$636.4K</td>
<td>1.1K</td>
<td>984</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.25</td>
<td>$5.15</td>
<td>$5.15</td>
<td>$100.00</td>
<td>$257.5K</td>
<td>4.6K</td>
<td>500</td>
</tr>
</tbody>
</table>

<h3>About Novo Nordisk</h3>
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
<h3>Where Is Novo Nordisk Standing Right Now?</h3>
<ul>
<li>With a volume of 4,857,497, the price of NVO is up 2.5% at $105.2. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 68 days.</li>
</ul>
<h3>What Analysts Are Saying About Novo Nordisk</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $160.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $160. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Novo Nordisk, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Smart Money Is Betting Big In NVO Options

Gruma Executing Well, But Sentiment And Margin Leverage Could Be More Challenging Soon

Comments

Gruma SAB

Gruma SAB (GMKKY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga